Bmal1 Deletion in Myeloid Cells Attenuates Atherosclerotic Lesion Development and Restrains Abdominal Aortic Aneurysm Formation in Hyperlipidemic Mice

Arterioscler Thromb Vasc Biol. 2020 Jun;40(6):1523-1532. doi: 10.1161/ATVBAHA.120.314318. Epub 2020 Apr 23.

Abstract

Objective: Although the molecular components of circadian rhythms oscillate in discrete cellular components of the vasculature and many aspects of vascular function display diurnal variation, the cellular connections between the molecular clock and inflammatory cardiovascular diseases remain to be elucidated. Previously we have shown that pre- versus postnatal deletion of Bmal1 (brain and muscle aryl hydrocarbon receptor nuclear translocator-like 1), the nonredundant core clock gene has contrasting effects on atherogenesis. Here we investigated the effect of myeloid cell Bmal1 deletion on atherogenesis and abdominal aortic aneurysm formation in mice. Approach and Results: Mice lacking Bmal1 in myeloid cells were generated by crossing Bmal1 flox/flox mice with lysozyme 2 promoter-driven Cre recombinase mice on a hyperlipidemic low-density lipoprotein receptor-deficient background and were fed on a high-fat diet to induce atherosclerosis. Atherogenesis was restrained, concomitant with a reduction of aortic proinflammatory gene expression in myeloid cell Bmal1 knockout mice. Body weight, blood pressure, blood glucose, triglycerides, and cholesterol were unaltered. Similarly, myeloid cell depletion of Bmal1 also restrained Ang II (angiotensin II) induced formation of abdominal aortic aneurysm in hyperlipidemic mice. In vitro, RNA-Seq analysis demonstrated a proinflammatory response in cultured macrophages in which there was overexpression of Bmal1.

Conclusions: Myeloid cell Bmal1 deletion retards atherogenesis and restrains the formation of abdominal aortic aneurysm and may represent a potential therapeutic target for inflammatory cardiovascular diseases.

Keywords: Bmal1; abdominal aortic aneurysm; atherosclerosis; myeloid cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ARNTL Transcription Factors / deficiency*
  • ARNTL Transcription Factors / genetics
  • ARNTL Transcription Factors / physiology*
  • Angiotensin II / pharmacology
  • Animals
  • Aortic Aneurysm, Abdominal / chemically induced
  • Aortic Aneurysm, Abdominal / prevention & control*
  • Atherosclerosis / etiology
  • Atherosclerosis / pathology
  • Atherosclerosis / prevention & control*
  • Cells, Cultured
  • Crosses, Genetic
  • Diet, High-Fat
  • Gene Deletion
  • Gene Expression
  • Hyperlipidemias / complications*
  • Hyperlipidemias / etiology
  • Inflammation
  • Integrases / genetics
  • Macrophages, Peritoneal / chemistry
  • Macrophages, Peritoneal / physiology
  • Mice
  • Mice, Knockout
  • Muramidase / genetics
  • Myeloid Cells / chemistry*
  • Promoter Regions, Genetic / genetics
  • Receptors, LDL / deficiency
  • Receptors, LDL / genetics

Substances

  • ARNTL Transcription Factors
  • Bmal1 protein, mouse
  • Receptors, LDL
  • Angiotensin II
  • Cre recombinase
  • Integrases
  • Muramidase